ðè§£çŠâ ã€ã³ãã«ãšã³ã¶ã¯ã¯ãã³â
ã€ã³ãã«ãšã³ã¶ã¯ã¯ãã³æ¥çš®ðã®ãäºçŽãåä»äžã§ã
2025ïœ2026ç§å¬ã·ãŒãºã³ã®æ ªã¯ä»¥äžã«æ±ºå®ããŸããã
ïŒ¡åæ ª
- A/ãã¯ããªã¢/4897/2022ïŒIVR-238ïŒïŒH1N1ïŒ
- A/ããŒã¹/722/2024ïŒIVR-262ïŒïŒH3N2ïŒ
ïŒ¢åæ ª
- B/ãªãŒã¹ããªã¢/1359417/2021ïŒBVR-26ïŒïŒãã¯ããªã¢ç³»çµ±ïŒ
æ°ä»ããŸãããïŒ
ãããå»å¹ŽãŸã§ã®4䟡ããã3䟡ã«ãªããŸããã
ðŠ ã¯ã¯ãã³ã®æ ªã®æŽå²
ãŸãã¯ãã€ã³ãã«ãšã³ã¶ã¯ã¯ãã³ã®æŽå²ãæ¯ãè¿ããŸãããã
1930幎代ïŒã€ã³ãã«ãšã³ã¶ãŠã€ã«ã¹ãåé¢ã»åå®ãããã
ã1933幎ãAåçºèŠã
ã1940幎ãBåçºèŠã
1940幎代ïŒç¬¬äºæ¬¡äžç倧æŠäžãç±³è»åãã«äžæŽ»åã¯ã¯ãã³ãéçºã»äœ¿çšããå§ããã
1960幎代ïŒäžæŽ»åã¯ã¯ãã³ãäžè¬ã«ãåºã䜿ãããããã«ãªãã
1970幎代ïŒåœå㯠2䟡ïŒA/H1N1ãšA/H2N2ãªã©ïŒ ã䜿ãããŠãããã
ã1977幎ãH1N1åãåæµè¡ããAåã2çš®é¡ïŒH1N1ãšH3N2ïŒåæã«ååšããããã«ãªã£ãã
ãããã§ã3äŸ¡ãæšæºã«ãªããŸããã
- Aå H1N1ïŒå£ç¯åïŒ2009幎以éã¯ãã³ãããã¯H1N1ïŒ
- Aå H3N2
- BåïŒãã¯ããªã¢ç³»çµ± ãŸã㯠山圢系統ã®ã©ã¡ããäžæ¹ïŒ
2000幎代åŸåã2010幎代ååïŒ
ãããããããBåã¯ãã¯ããªã¢ç³»çµ±ãšå±±åœ¢ç³»çµ±ã亀äºã«æµè¡ãããã°ãã°äºæž¬ãå€ããããšãåé¡ã«ãªãã
ãããããããWHOãååœç ç©¶æ©é¢ãããäž¡æ¹ã®Bãå«ããã»ããããããšããæèšãåºå§ããã
ã2012幎ãWHOã®ã¯ã¯ãã³æ ªã®æšå¥šã«ãããŠãåããŠ4䟡ã¯ã¯ãã³ã®å©çšãæ£åŒã«ææ¡ã
ã2013幎ãCDCã4äŸ¡ãæšå¥šããã®åŸã欧å·ã§ãåºãŸãã
ã2015幎ãäžççãª4äŸ¡æšæºåãåããŠãæ¥æ¬ã§ã4äŸ¡ãæšæºå
ã2023幎ãäžççã«BåïŒç¹ã«å±±åœ¢ç³»çµ±ïŒã®èªç¶æµè¡ãã»ãšãã©ç¢ºèªãããªããªã£ãã
ãããããã9æã«WHOãBå山圢系統ãã¯ã¯ãã³æ ªããé€å€ããããæšå¥šã
ã2025å¹Žãæ¥æ¬ã§ã4䟡ãã3䟡ã«å€æŽã
åœé¢ã¯2015幎ã«éæ¥ããã®ã§ãããªãæ ªãå¢ããã®ãïŒããšããã質åãããåããã®ãèŠããŠããŸãã
ãã®ã¿ã€ãã³ã°ã§ãè¬å€åžããã®åžæå°å£²äŸ¡æ Œã1.5åã«è·³ãäžãããã¯ã¯ãã³ã®äŸ¡æ Œãå€äžããããŸããã
ã«ã«ãã«ã§ã¯ãªãããšãæ¥æ¬å»äºæ°å ±ç€Ÿã«è³ªåãæ²èŒãããŸããã
æ£çŽãªãšãããä»åã3äŸ¡ã«æ»ã£ãŠäžçªãæåŸ å€ãã ã£ãã®ã¯ãå€äžããããªãã£ãŠããšã§ãã
äŸå¹Žéããè·å Žã§ã®é壿¥çš®ãäŒæ¥è² æ ã®é¢å æ¥çš®ãæ±æ¯åããã³ããŸã®åµå¥ã®è£å©ã«å¯Ÿå¿ããŠãããŸãã
ãããã€ãã®æ¹ããè¿æã®æ¹ã¯ãçŽæ¥ã®ãé£çµ¡ããåä»ããŠãããŸãã
ç¹ã«ãè¿æã®æ¹ã«ã¯ãææžå²åŒã¯ã¯ãã³ã宿œããŸãïŒïŒ1ãã€ã¢ã«ã§2ååã®ããã廿£ãé¿ããããã«ãååããã ããå Žåã¯ãå²åŒããŸãïŒ
ð¡ æ¥çš®ã¿ã€ãã³ã°ã®ç®å®
æ¥çš®åŸ2ã3é±éã§æäœãã€ããçŽ5ãæå¹æãç¶ããŸãã
åœç«ææçç ç©¶æã®ããŒã¿ãããå€ãã®å¹Žã§ããŒã¯ã¯1æã2æãç¹ã«2æäžæ¬ãæå€ã§ãã
ãã ããè¿å¹Žã¯å¹Žå 11æã12æã«æ©ãã«ç«ã¡äžããã±ãŒã¹ãå¢ããŠããŸããã11æãš2æã«äºå³°æ§ã®ããŒã¯ããã幎ããããŸãã
æšå¹ŽïŒ2023/24ã·ãŒãºã³ïŒã¯ã第49é±ïŒ2023幎12æ4æ¥ã10æ¥ïŒ ã«ãå šåœã®å®ç¹åœããå ±åæ°ã 33.73 ãšãªããæåã®ããŒã¯ãè¿ããŸããã
10æäžã®æ¥çš®ã§ã11æã«ããŒã¯ãããŠãã幎æ«å¹Žå§ããåéšææããæ¥å ãŸã§ãã«ããŒã§ããŸãã
äŸå¹Žã11æã«å ¥ããšäºçŽãæ··ã¿åããã¯ã¯ãã³ãåèã«ãªãããšããããŸãã
確å®ã«æ¥çš®ãããæ¹ã¯ãæ©ãã®ãäºçŽãããããããŸãã
ãäºçŽåã¯ã確ä¿ããŠãããŸãã®ã§ãé ãæ¥çš®åžæã®æ¹ããæ©ãã«ãäºçŽãã ããã
ðåã人ãã¯ã¯ãã³ãåããæå³
ã€ã³ãã«ãšã³ã¶ã¯ã¯ãã³ãæ¥çš®ããŠããææãå®å šã«ãããã¯ããããšã¯ã§ããŸããã
ðCDCãNIIDã®ããŒã¿ãéã¿ããšãã·ãŒãºã³å¹³åãããš 40ã60ïŒ çšåºŠã®ãçºçãäºé²å¹æããããŸããããã¯çºçã§ãããææãšã€ã³ãŒã«ã§ã¯ãããŸãããã§ããææããŠæ°ã¥ããªããªããå¥ã«ããããïŒ
ã€ãŸããæ¥çš®ããäººã¯æ¥çš®ããªãã£ãäººã«æ¯ã¹ãŠãããã確çãååãããã«ãªããã€ã¡ãŒãžã§ãã
äžèŽåºŠãé«ã幎ã«ã¯ã60ïŒ ä»¥äžã®äºé²å¹æãèŠãããããšããããŸãããå察ã«ãäžèŽåºŠãäœã幎ãç¹ã«A/H3N2æ ªã®å¹Žã«ã¯ã10ã20ïŒ ãŸã§èœã¡ãããšããããŸãã
æãæåŸ ã§ããã¯ã¯ãã³ã®å¹æã¯éçåäºé²ã§ãå°å ã®å ¥é¢ãªã¹ã¯ã40ã70ïŒ äœäžãããé«éœ¢è ã§ã®èºçã»æ»äº¡ãªã¹ã¯äœäžïŒ40ã60ïŒ ãããŸããåŠå©Šããã²ãåããŠãã ããã
ããããç§ãã¡ç€ŸäŒäººãã€ã³ãã«ãšã³ã¶ã¯ã¯ãã³ãæ¥çš®ããç®çã®ç¬¬äžã¯ãçç£æ§ã®äœäžãé¿ããããšã§ãã
ãããŠãããäžã€æèããŠã»ããããšã¯ãäžã®äžã«ã¯çµ¶å¯Ÿã«ã€ã³ãã«ãšã³ã¶ææãé¿ãããå ç«æå¶ç¶æ ã®æ¹ãå°æ°ååšãã圌ãã¯å ç«æå¶ããã«ãã¯ã¯ãã³ãæ¥çš®ã§ããªããšããããšã§ããåã人ã®äžã«ã¯ãå ç«æå¶ç¶æ ã®æ¹ã¯ã»ãšãã©ããªããå æ°ãªèªåã®å¥åº·ãå¢é²ããªãããå©ããå¿ èŠãšããŠãã人ã®åã«ãªããéå£å ç«ã¯ãæ¬åœã«çŽ æµãªççã§ãã

ç ç©¶ã»è«æåã»å ±å | 察象ã»åœ | äž»ãªææã»çµè« | ç¹èšäºé ã»çæç¹ |
Influenza cost and cost-effectiveness studies globally â A review | åœé | äžçååœã«ãããã€ã³ãã«ãšã³ã¶ã¯ã¯ãã³ã®ã³ã¹ããšã³ã¹ã广ã®ç ç©¶ãç·èЧ | å€åœéã»ææ³ã®ã°ãã€ããããæ¯èŒã«ã¯æ³šæãå¿ èŠ (ãµã€ãšã³ã¹ãã€ã¬ã¯ã) |
Costs and cost-effectiveness of influenza illness and vaccination in low- and middle-income countriesïŒã·ã¹ãããã£ãã¯ã¬ãã¥ãŒïŒ | LMICïŒéäžåœãäžæåŸåœïŒ | 54ä»¶ã®ç ç©¶ãåæã察象éå£å¥ïŒåã©ããé«éœ¢è ãåºç€çŸæ£ãããªã©ïŒã§ã¯ã¯ãã³å°å ¥ããè²»çšå¯Ÿå¹æããããã³ã¹ãç¯çŽåããšè©äŸ¡ãããäºäŸå€æ°ãã (PLOS) | |
Economic evaluation of seasonal influenza vaccination in elderly and healthcare workers | è«æïŒé«éœ¢è ã»å»çåŸäºè 察象ãè€æ°åœããŒã¿ãçšããçµ±åïŒ | æ¥çš®çŸ€ãšéæ¥çš®çŸ€ã®ãéçæ£å³äŸ¿çïŒIncremental Net Monetary Benefits, INMBïŒããæ¯èŒããã¯ã¯ãã³æ¥çš®ãçµæžçã«åççã§ããããšã瀺ã | é«éœ¢è ã»å»çåŸäºè ã«å¯Ÿããå¹çšè©äŸ¡ãå®éå (ã©ã³ã»ãã) |
Cost-Effectiveness Analysis for Influenza Vaccination Scheduling | ã·ã³ã¬ããŒã«ã»å°åã»æ±äº¬ãªã©ïŒã·ãã¥ã¬ãŒã·ã§ã³ã¢ãã«ïŒ | æ¥çš®ã¹ã±ãžã¥ãŒã«ã®æé©åãã¢ãã«åããã³ã¹ã广æ§ãåŸãããæ¡ä»¶ãæ€èš | å°åæ§ã»ã¢ãã«ä»®å®ã«äŸåããçµæ (ãµã€ãšã³ã¹ãã€ã¬ã¯ã) |
Effect of influenza vaccine subsidies for older adultsïŒæ¥æ¬ïŒ | æ¥æ¬ïŒåžåºçºæåäœïŒ | é«éœ¢è ã®èªå·±è² æ ãåŒãäžããè£å©ã宿œããèªæ²»äœã§ã¯ãæ¥çš®çãäžæãèªå·±è² æ ã1000åäžãããšæ¥çš®çãçŽ6.3ïŒ äžãããšæšå®ããã ããæ»äº¡çãšã®é¢é£ã¯æç¢ºåã§ããã (Keio University) | |
Evaluating the Economic Benefit of Improved High-Dose Influenza Vaccine Coverage in Tokyo | æ¥æ¬ïŒæ±äº¬ã®é«éœ¢è ïŒ | æšæºåã¯ã¯ãã³ããé«å®¹éïŒHigh-doseïŒã¯ã¯ãã³ãžã®è»¢æãæ³å®ããã¢ãã«ã§ãå»çãªãœãŒã¹åæžå¹æã»è²»çšäŸ¿çãåæäž (ISPOR.org) | |
Influenza, Healthy Ageing and Economic Resilience in JapanïŒå ±åæžïŒ | æ¥æ¬ | é«éœ¢å瀟äŒã«ãããã€ã³ãã«ãšã³ã¶ã«ããå ¬è¡è¡çã»çµæžçè² æ ãè°è«ããé«å®¹éã¯ã¯ãã³ïŒé«éœ¢è åãïŒãå°å ¥ã®ã³ã¹ã广ãè«ããŠãã (Asia House) | |
A benefit-cost analysis quantifying the broader socioeconomic value of adult respiratory vaccination programs in Japan | æ¥æ¬ | æäººåŒåžåšç³»ã¯ã¯ãã³ïŒã€ã³ãã«ãšã³ã¶å«ãïŒããã°ã©ã ã®ç€ŸäŒçµæžç䟿çã詊ç®ã5幎éã§ãããã£ããã»ã³ã¹ãæ¯ïŒBCRïŒã¯çŽ 18:1ãçæ¶¯åž°çµã§ 20:1 ã«éãããšããæšå®çµæã瀺ããŠãã (nevinmanimala.com) |
ã©ãããããããé¡ãããŸãã
